Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Current Deferred Revenue (2020 - 2025)

Sotera Health (SHC) has 6 years of Current Deferred Revenue data on record, last reported at $18.0 million in Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 19.21% year-over-year to $18.0 million; the TTM value through Dec 2025 reached $18.0 million, up 19.21%, while the annual FY2025 figure was $18.0 million, 19.21% up from the prior year.
  • Current Deferred Revenue reached $18.0 million in Q4 2025 per SHC's latest filing, up from $14.1 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $18.0 million in Q4 2025 and bottomed at $4.9 million in Q3 2021.
  • Average Current Deferred Revenue over 5 years is $11.3 million, with a median of $12.8 million recorded in 2022.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 139.85% in 2023, then decreased 16.2% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $8.7 million in 2021, then surged by 39.58% to $12.1 million in 2022, then rose by 11.5% to $13.5 million in 2023, then rose by 11.92% to $15.1 million in 2024, then rose by 19.21% to $18.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $18.0 million in Q4 2025, $14.1 million in Q3 2025, and $11.5 million in Q2 2025.